Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 801

1.

The effect of lifelong exercise frequency on arterial stiffness.

Shibata S, Fujimoto N, Hastings JL, Carrick-Ranson G, Bhella PS, Hearon C, Levine BD.

J Physiol. 2018 May 20. doi: 10.1113/JP275301. [Epub ahead of print]

PMID:
29781119
2.

Effect of Sitagliptin on Coronary Flow Reserve Assessed by Magnetic Resonance Imaging in Type 2 Diabetic Patients With Coronary Artery Disease.

Moriwaki K, Takeuchi T, Fujimoto N, Sawai T, Sato Y, Kumagai N, Masuda J, Nakamori S, Ishida M, Yamada N, Nakamura M, Sakuma H, Ito M, Dohi K.

Circ J. 2018 May 12. doi: 10.1253/circj.CJ-18-0083. [Epub ahead of print]

3.

Auftreten einer Psoriasis vulgaris bei einem Patienten mit Pemphigus vulgaris unter Kortikosteroidtherapie.

Fujimoto N, Matsuo S, Satoh T.

J Dtsch Dermatol Ges. 2018 May;16(5):605-607. doi: 10.1111/ddg.13505_g. No abstract available.

PMID:
29750447
4.

Pre-treatment evaluation of FRET-based drug sensitivity test for patients with CML treated with dasatinib.

Kondo T, Fujioka M, Tsuda M, Murai K, Yamaguchi K, Miyagishima T, Shindo M, Nagashima T, Wakasa K, Fujimoto N, Yamamoto S, Yonezumi M, Saito S, Sato S, Ogawa K, Chou T, Watanabe R, Kato Y, Takahashi S, Okano Y, Yamamoto J, Ohta M, Iijima H, Oba K, Kishino S, Sakamoto J, Ishida Y, Ohba Y, Teshima T; Inter-Michinoku Dasatinib Study Group (IMIDAS).

Cancer Sci. 2018 May 2. doi: 10.1111/cas.13625. [Epub ahead of print]

5.

Prospective registry database of patients with malignant mesothelioma: directions for a future Japanese registry-based lung cancer study.

Shintani Y, Hasegawa S, Takuwa T, Aoe K, Kato K, Fujimoto N, Hida Y, Morise M, Moriya Y, Morohoshi T, Okumura M, Yoshino I.

J Thorac Dis. 2018 Mar;10(3):1968-1971. doi: 10.21037/jtd.2018.03.53.

6.

Psoriasis vulgaris in a patient with pemphigus vulgaris on corticosteroid therapy.

Fujimoto N, Matsuo S, Satoh T.

J Dtsch Dermatol Ges. 2018 May;16(5):606-608. doi: 10.1111/ddg.13505. Epub 2018 Apr 24. No abstract available.

PMID:
29689136
7.

Interaction between cardiac myosin-binding protein C and formin Fhod3.

Matsuyama S, Kage Y, Fujimoto N, Ushijima T, Tsuruda T, Kitamura K, Shiose A, Asada Y, Sumimoto H, Takeya R.

Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4386-E4395. doi: 10.1073/pnas.1716498115. Epub 2018 Apr 23.

PMID:
29686099
8.

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.

Nagamatsu Y, Oze I, Aoe K, Hotta K, Kato K, Nakagawa J, Hara K, Kishimoto T, Fujimoto N.

BMC Cancer. 2018 Mar 27;18(1):350. doi: 10.1186/s12885-018-4293-x.

9.

The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients.

Ito T, Fujimoto N, Ishikawa E, Dohi K, Fujimoto M, Murata T, Kiyohara M, Takeuchi H, Koyabu S, Nishimura H, Takeuchi T, Ito M.

Clin Exp Hypertens. 2018 Mar 27:1-8. doi: 10.1080/10641963.2018.1445753. [Epub ahead of print]

PMID:
29584458
10.

Low-dose chest computed tomography screening of subjects exposed to asbestos.

Kato K, Gemba K, Ashizawa K, Arakawa H, Honda S, Noguchi N, Honda S, Fujimoto N, Kishimoto T.

Eur J Radiol. 2018 Apr;101:124-128. doi: 10.1016/j.ejrad.2018.02.017. Epub 2018 Feb 16.

PMID:
29571785
11.

[Validation of the Kit for Detecting Mycoplasma Genitalium from the Male Urethritis].

Hamasuna R, Matsumoto M, Thi LE P, Fujimoto N, Matsumoto T.

J UOEH. 2018;40(1):45-52. doi: 10.7888/juoeh.40.45. Japanese.

12.

Clinical features of secondary spontaneous pneumothorax complicated with silicosis.

Iga N, Nishi H, Fujimoto N, Kishimoto T.

Respir Investig. 2018 Mar;56(2):144-149. doi: 10.1016/j.resinv.2017.11.007. Epub 2018 Mar 1.

PMID:
29548652
13.

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform.

Katayama H, Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe Y, Ohishi K, Yamashita Y, Ikejiri M, Habe K, Katayama N.

Clin Appl Thromb Hemost. 2018 Jan 1:1076029618757344. doi: 10.1177/1076029618757344. [Epub ahead of print]

PMID:
29439640
14.

Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis.

Yamagami J, Nakamura Y, Nagao K, Funakoshi T, Takahashi H, Tanikawa A, Hachiya T, Yamamoto T, Ishida-Yamamoto A, Tanaka T, Fujimoto N, Nishigori C, Yoshida T, Ishii N, Hashimoto T, Amagai M.

J Invest Dermatol. 2018 Feb 2. pii: S0022-202X(18)30039-3. doi: 10.1016/j.jid.2017.12.035. [Epub ahead of print]

PMID:
29410066
15.

Erythema nodosum-like eruption after uterine artery embolization: a case report and literature review.

Yoneta K, Fujii N, Dendo S, Kato T, Tanaka T, Fujimoto N.

Eur J Dermatol. 2018 Apr 1;28(2):239-240. doi: 10.1684/ejd.2017.3195. No abstract available.

PMID:
29400291
16.

Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ.

Tomisaki I, Kubo T, Minato A, Fujimoto N.

Cancer Invest. 2018 Feb 7;36(2):152-157. doi: 10.1080/07357907.2018.1430815. Epub 2018 Feb 2.

PMID:
29393701
17.

Identification of hepatic thyroid hormone-responsive genes in neonatal rats: Potential targets for thyroid hormone-disrupting chemicals.

Fujimoto N, Kitamura S, Uramaru N, Miyagawa S, Iguchi T.

Toxicol Lett. 2018 Apr;286:48-53. doi: 10.1016/j.toxlet.2018.01.005. Epub 2018 Feb 2.

PMID:
29357290
18.

Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).

Takahashi R, Miyazato M, Nishii H, Sumino Y, Takayama K, Onzuka M, Oshiro T, Saito S, Fujimoto N, Mimata H, Eto M.

Low Urin Tract Symptoms. 2018 Jan;10(1):76-83. doi: 10.1111/luts.12143. Epub 2016 Nov 5.

PMID:
29341501
19.

Left Ventricular Volume-Time Relation in Patients With Heart Failure With Preserved Ejection Fraction.

Hieda M, Parker J, Rajabi T, Fujimoto N, Bhella PS, Prasad A, Hastings JL, Sarma S, Levine BD.

Am J Cardiol. 2018 Mar 1;121(5):609-614. doi: 10.1016/j.amjcard.2017.11.033. Epub 2017 Dec 11.

PMID:
29306483
20.

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404.

Ninomiya T, Nogami N, Kozuki T, Harada D, Kubo T, Ohashi K, Kuyama S, Kudo K, Bessho A, Fukamatsu N, Fujimoto N, Aoe K, Shibayama T, Sugimoto K, Takigawa N, Hotta K, Kiura K.

Lung Cancer. 2018 Jan;115:103-108. doi: 10.1016/j.lungcan.2017.11.025. Epub 2017 Nov 28.

PMID:
29290249

Supplemental Content

Loading ...
Support Center